Cardio-oncologyis the emerging sector of monitoring, preventing, and treating cardiovasculardamage caused by cancer treatments such as chemotherapyand radiation therapy. It is important to check the patients periodically underthe treatment particularly for the patients who intake anthracyclinesand trastuzumab. The management of cardiovascularrisk factors and periodic diagnosing with cardiacimaging and biomarkers should be taken into account in high-risk survivors.
Related: Cardiology Summit | Cardiology Conference|Cardio Congress |Heart DiseaseConference |Heart Conference |HypertensionConference | Cardiologywebinar |CardiologyConference | Heart Congress
Related Associations&Societies: Nigerian Heart Foundation |American Society for Echocardiography|Singapore Cardiac Society |American Society for Preventive Cardiology |American HeartAssociation| American Society for Preventive Cardiology| AmericanSociety for Echocardiography| National HeartFoundation of Australia
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
